Arkolith/Insider Trading/MIST/Form 4

Muller Lorenz

Chief Commercial OfficerMilestone Pharmaceuticals Inc. (MIST) · full profile →Form 4 · filed Jul 15, 2025
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
3
1 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jul 11, 2025Grant(A)67K——175K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jul 11, 2025Grant(A)67K——67K
Jul 11, 2025Grant(A)67K——67K

Transaction Codes

A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001415889-25-019771) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML